Santa Clara, CA 9/19/13; Santa Clara, 9/19/13—Agilent Technologies has announced plans to spin off its Electronic Measurement division as a separately traded public company. The remaining business, consisting of the company’s Life Sciences, Chemical Analysis and Diagnostics segments, will retain the Agilent name and continue under President and CEO William Sullivan. Those businesses are estimated […]
Major changes at the top analytical instrument companies continue to unfold. This month, Agilent Technologies, the second-largest analytical and life science instrument company (see IBO 4/15/13), announced that it will spin off its Electronic Measurement Group (EM), transforming it into a company dedicated to laboratory instrumentation. This follows the April announcement of the acquisition of […]
Company Announcements Teledyne Technologies promoted Al Pichelli, president and CEO of the Instrumentation, and Aerospace and Defense Electronics segments, to executive vice president. In July, Thermo Fisher Scientific established the China Innovation Center in Shanghai. The $9.5 million Center is expected to add 200–300 engineers over the next two to three years. The Center includes […]
Second quarter 2013 IBO Life Science Index sales grew 2.6%, 4.5% excluding currency, to $3,408 million. Operating profit was flat at $701 million. Based on continuing operations, operating margin slipped 70 basis points to 20.6% of sales. Fiscal third quarter revenue for Becton, Dickinson’s BD Biosciences division declined 4.2%, 2.5% excluding currency, to $257.1 million […]
Major US equity markets were volatile in August due to uncertainty surrounding the Federal Reserve’s quantitative easing policy, potential military intervention in Syria and mixed economic data. In the US, second quarter GDP was revised up from 1.7% growth to 2.5% growth and unemployment claims declined to a five-year low. However, US orders for both […]
Major, publicly held analytical instrument companies continued to operate in a uncertain market environment in the calendar year second quarter. Industrial, environmental and academic markets remained under pressure for the most part. However, Chinese, food safety, pharmaceutical and aftermarket sales were healthy. Conversion of first quarter orders benefited Bruker and PerkinElmer (see IBO 5/31/13). For […]
In this article, IBO examines free cash flow (FCF) for the first six months of 2013 at seven major publicly held instrument and lab product companies, and details how the companies are spending and plan to spend their cash. Excluding certain one-time payments, FCF (operating cash flow less net capital investments) for six of the […]
Company Announcements In May, QIAGEN opened the QIAGEN (Suzhou) Translational Medicine Center to accelerate the discovery and validation of biomarkers and create companion diagnostics for the Chinese market. The Center is a joint venture with BioBAY, a life sciences cluster located near Shanghai. QIAGEN (Suzhou) is expected to grow to about 50 employees within three […]
Second quarter revenues for IBO’s Laboratory Instrument Sales Index grew 4.5%, 4.9% excluding currency, to $5,999 million. Operating profit advanced 3.8% to $1,200 million. Based on continuing operations, operating margin slipped 10 basis points to 17.6% of sales. Modest growth rates are included for Oxford Instruments, which did not report earnings before this issue’s publication. […]
Calgary, Canada 8/2/13; Calgary, Canada 8/7/13; Calgary, Canada 8/7/13; Toronto, Canada 8/7/13; Toronto, Canada 8/1/13; Toronto, Canada 8/5/13; Toronto, Canada 8/14/13— On August 7, 1756349 Alberta completed its offer to purchase the outstanding shares of Galvanic Applied Sciences, a provider of online analytical instrumentation for natural gas and liquid processing, for CAD 1.70 per share […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
